Market Closed -
Japan Exchange
02:00:00 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
987
JPY
|
+0.51%
|
|
-1.00%
|
+10.65%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
9,241
|
9,781
|
8,995
|
8,904
|
8,007
|
8,120
|
Enterprise Value (EV)
1 |
6,284
|
6,609
|
5,914
|
5,345
|
4,502
|
4,528
|
P/E ratio
|
13.8
x
|
13.5
x
|
13.9
x
|
13.5
x
|
17.4
x
|
52.7
x
|
Yield
|
3.53%
|
3.52%
|
3.74%
|
3.78%
|
4.2%
|
4.15%
|
Capitalization / Revenue
|
0.86
x
|
0.9
x
|
0.83
x
|
0.76
x
|
0.65
x
|
0.65
x
|
EV / Revenue
|
0.58
x
|
0.61
x
|
0.55
x
|
0.46
x
|
0.37
x
|
0.36
x
|
EV / EBITDA
|
4.69
x
|
4.49
x
|
4.25
x
|
4.02
x
|
3.37
x
|
3.26
x
|
EV / FCF
|
23.8
x
|
10.5
x
|
7.76
x
|
-1,379
x
|
13.5
x
|
16.4
x
|
FCF Yield
|
4.2%
|
9.55%
|
12.9%
|
-0.07%
|
7.42%
|
6.11%
|
Price to Book
|
0.72
x
|
0.74
x
|
0.68
x
|
0.63
x
|
0.54
x
|
0.54
x
|
Nbr of stocks (in thousands)
|
9,315
|
9,315
|
9,095
|
9,095
|
9,099
|
9,104
|
Reference price
2 |
992.0
|
1,050
|
989.0
|
979.0
|
880.0
|
892.0
|
Announcement Date
|
3/28/19
|
3/27/20
|
3/30/21
|
3/30/22
|
3/30/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
10,796
|
10,843
|
10,830
|
11,698
|
12,257
|
12,585
|
EBITDA
1 |
1,341
|
1,472
|
1,390
|
1,329
|
1,338
|
1,391
|
EBIT
1 |
993
|
1,083
|
985
|
867
|
738
|
803
|
Operating Margin
|
9.2%
|
9.99%
|
9.1%
|
7.41%
|
6.02%
|
6.38%
|
Earnings before Tax (EBT)
1 |
979
|
1,101
|
983
|
965
|
836
|
904
|
Net income
1 |
672
|
725
|
659
|
660
|
460
|
154
|
Net margin
|
6.22%
|
6.69%
|
6.08%
|
5.64%
|
3.75%
|
1.22%
|
EPS
2 |
72.14
|
77.83
|
71.13
|
72.57
|
50.56
|
16.92
|
Free Cash Flow
1 |
263.9
|
630.9
|
762.2
|
-3.875
|
333.9
|
276.6
|
FCF margin
|
2.44%
|
5.82%
|
7.04%
|
-0.03%
|
2.72%
|
2.2%
|
FCF Conversion (EBITDA)
|
19.68%
|
42.86%
|
54.84%
|
-
|
24.95%
|
19.89%
|
FCF Conversion (Net income)
|
39.27%
|
87.02%
|
115.67%
|
-
|
72.58%
|
179.63%
|
Dividend per Share
2 |
35.00
|
37.00
|
37.00
|
37.00
|
37.00
|
37.00
|
Announcement Date
|
3/28/19
|
3/27/20
|
3/30/21
|
3/30/22
|
3/30/23
|
3/28/24
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2021 Q3
|
2022 Q1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
---|
Net sales
1 |
5,082
|
5,479
|
2,852
|
2,928
|
6,029
|
3,136
|
2,870
|
6,025
|
3,143
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
400
|
487
|
267
|
165
|
333
|
226
|
125
|
335
|
277
|
Operating Margin
|
7.87%
|
8.89%
|
9.36%
|
5.64%
|
5.52%
|
7.21%
|
4.36%
|
5.56%
|
8.81%
|
Earnings before Tax (EBT)
1 |
390
|
576
|
262
|
235
|
542
|
308
|
144
|
396
|
272
|
Net income
1 |
248
|
408
|
188
|
132
|
311
|
233
|
129
|
316
|
-307
|
Net margin
|
4.88%
|
7.45%
|
6.59%
|
4.51%
|
5.16%
|
7.43%
|
4.49%
|
5.24%
|
-9.77%
|
EPS
2 |
26.64
|
44.91
|
20.63
|
14.59
|
34.21
|
25.61
|
14.26
|
34.78
|
-33.72
|
Dividend per Share
|
17.00
|
17.00
|
-
|
-
|
17.00
|
-
|
-
|
17.00
|
-
|
Announcement Date
|
8/4/20
|
8/4/21
|
10/28/21
|
5/6/22
|
8/4/22
|
10/31/22
|
5/8/23
|
8/4/23
|
10/31/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
2,957
|
3,172
|
3,081
|
3,559
|
3,505
|
3,592
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
264
|
631
|
762
|
-3.88
|
334
|
277
|
ROE (net income / shareholders' equity)
|
5.22%
|
5.56%
|
4.99%
|
4.81%
|
3.18%
|
1.04%
|
ROA (Net income/ Total Assets)
|
3.6%
|
3.94%
|
3.59%
|
3.08%
|
2.5%
|
2.63%
|
Assets
1 |
18,676
|
18,420
|
18,334
|
21,420
|
18,421
|
5,849
|
Book Value Per Share
2 |
1,383
|
1,414
|
1,454
|
1,564
|
1,618
|
1,641
|
Cash Flow per Share
2 |
460.0
|
465.0
|
437.0
|
479.0
|
473.0
|
482.0
|
Capex
1 |
420
|
238
|
228
|
299
|
260
|
435
|
Capex / Sales
|
3.89%
|
2.19%
|
2.11%
|
2.56%
|
2.12%
|
3.46%
|
Announcement Date
|
3/28/19
|
3/27/20
|
3/30/21
|
3/30/22
|
3/30/23
|
3/28/24
|
|
1st Jan change
|
Capi.
|
---|
| +10.65% | 56.12M | | +8.96% | 26.92B | | -31.01% | 3.12B | | -15.97% | 2.52B | | +18.11% | 2.47B | | +3.70% | 2B | | -9.47% | 1.91B | | -2.22% | 1.48B | | +2.24% | 1.31B | | +18.92% | 1.18B |
Medical Supplies
|